1-9 of 9
Hanny Al-Samkari
Close
Sort by
Journal Articles

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women

Clinical Trials & Observations
Ellen Zhang, Zain M. Virk, Josanna Rodriguez-Lopez, Hanny Al-Samkari
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3166–3172.
https://doi.org/10.1182/bloodadvances.2023011961
Published: 2024
Includes: Supplemental data
Journal Articles

Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia

Daniel Wang, Satoko Ito, Christina Waldron, Ayesha Butt, Ellen Zhang, Harlan M. Krumholz, Hanny Al-Samkari, George Goshua
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2835–2845.
https://doi.org/10.1182/bloodadvances.2024012589
Published: 2024
Includes: Supplemental data
Journal Articles

Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency

Eduard J. van Beers, Hanny Al-Samkari, Rachael F. Grace, Wilma Barcellini, Andreas Glenthøj, Melissa DiBacco, Megan Wind-Rotolo, Rengyi Xu, Vanessa Beynon, Parija Patel, John B. Porter, Kevin H. M. Kuo
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2433–2441.
https://doi.org/10.1182/bloodadvances.2023011743
Published: 2024
Journal Articles

Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight

Brody H. Foy, Jonathan A. Stefely, Pavan K. Bendapudi, Robert P. Hasserjian, Hanny Al-Samkari, Abner Louissaint, Jr., Megan J. Fitzpatrick, Bailey Hutchison, Christopher Mow, Julia Collins, Hasmukh R. Patel, Chhaya H. Patel, Nikita Patel, Samantha N. Ho, Richard M. Kaufman, Walter H. Dzik, John M. Higgins, Robert S. Makar
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4621–4630.
https://doi.org/10.1182/bloodadvances.2022008967
Published: 2023
Includes: Supplemental data
Journal Articles

Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency

Clinical Trials & Observations
Hanny Al-Samkari, Eduard J. van Beers, D. Holmes Morton, Stefan W. Eber, Satheesh Chonat, Kevin H. M. Kuo, Nina Kollmar, Heng Wang, Vicky R. Breakey, Sujit Sheth, Mukta Sharma, Peter W. Forbes, Robert J. Klaassen, Rachael F. Grace
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1844–1853.
https://doi.org/10.1182/bloodadvances.2021004675
Published: 2022
Includes: Supplemental data
Journal Articles

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Clinical Trials & Observations
Andrew B. Song, Rahul Sakhuja, Nancy M. Gracin, Ronald Weinger, Raj S. Kasthuri, Hanny Al-Samkari
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3850–3854.
https://doi.org/10.1182/bloodadvances.2021004810
Published: 2021
Journal Articles

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

Hanny Al-Samkari, Rachel P. Rosovsky, Rebecca S. Karp Leaf, David B. Smith, Katayoon Goodarzi, Annemarie E. Fogerty, David B. Sykes, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 4 (1): 9–18.
https://doi.org/10.1182/bloodadvances.2019000868
Published: 2019
Includes: Supplemental data
Journal Articles

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Hanny Al-Samkari, Jean M. Connors
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3770–3779.
https://doi.org/10.1182/bloodadvances.2019000369
Published: 2019
Journal Articles

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Marie A. Hollenhorst, Hanny Al-Samkari, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3515–3521.
https://doi.org/10.1182/bloodadvances.2019000400
Published: 2019
Includes: Supplemental data